Supplemental Figure 1: Flow chart of women involved in the study
Women were selected from within a placebo controlled trial of chloroquine prophylaxis 1 .
Women who had at least one Plasmodium positive smear were classified as cases.
Within those cases women who had any P. falciparum (Pf) positive slide were classified as Pf case, and the same for P. Vivax (Pv) cases. If a woman had had both Pf and Pv positive smears during her pregnancy she would be classified as both Pf and Pv case.
Women enrolled in a chloroquine prophylaxis trial n = 1000
Women who had at least one Plasmodium positive smear during weekly screening n = 136 Multivariable linear regressions were performed on untransformed neonate to maternal antibody ratios. The ratios of antibodies were only calculated in 158 women who were seropositive for each antigen to eliminate very large ratios generated in seronegative women with very low optical densities. Coefficients represent the change in maternal-neonate antibody ratios. Representative examples of antibodies to Pf-IE, P. falciparum and P. vivax merozoites are shown. Similar patterns were observed with all other antigens (data not shown) as a trend of increased ratios towards 1 with increasing EGA. EGA -estimated gestational age (weeks).
